24 results for “clear”
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the European Industrial Hemp Association’s […]
The bill to legalise medical cannabis will now advance to its second reading in parliament.
Your weekly debrief of the latest cannabis news.
The European Parliament held its first ever debate on the legalisation of cannabis last week.
Potyque tackles some of the most common misconceptions about CBD oil.
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
The former heavyweight boxing contender revealed he is using prescribed medical cannabis to manage chronic pain.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
The guide aims to help patients travel safely, confidently, and within the law.
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.
YouGov has published a representative survey examining the British public’s attitudes towards cannabis.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
